PLx Pharma Inc (PLXP)
NASDAQ (CM) NASDAQ (CM) Primary Summary
PLx Pharma Inc (PLXP) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has PLx Pharma Inc ever had a stock split?
PLx Pharma Inc Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Natasha Giordano CEO | NASDAQ (CM) Exchange | 72942A107 CUSIP |
| US Country | 16 Employees | - Last Dividend | 20 Apr 2017 Last Split | - IPO Date |
Overview
PLx Pharma Inc. is a U.S.-based company that utilizes its innovative drug delivery platform technology and has successfully transitioned into the commercial stage. Headquartered in Sparta, New Jersey, PLx Pharma offers a range of pharmaceutical products aimed at managing various health conditions. The company was founded in 2002 and has carved out a niche in the market by focusing on effective solutions for vascular incidents, pain, inflammation, and fever management.
Products and Services
- Vazalore 325 mg:
This product is designed for individuals who are experiencing vascular incidents, such as heart attacks and clot-induced strokes. In addition to its cardiovascular applications, Vazalore 325 mg serves as a potent option for the management of pain and inflammation, enhancing patient care during critical health challenges.
- Vazalore 81 mg:
Available in liquid-filled aspirin capsules, Vazalore 81 mg offers a gentler formulation for those needing an aspirin regimen. This product is suitable for long-term cardiovascular health support and pain management, catering primarily to individuals who benefit from a lower dosage of aspirin.
- PL1200 Ibuprofen 200 mg:
This product is currently in Phase I clinical trials and aims to alleviate pain, reduce inflammation, and manage fever. By leveraging advanced drug delivery technology, PL1200 is being developed to provide effective relief with potentially improved patient outcomes.
- PL1100 Ibuprofen 400 mg:
Similar to PL1200, PL1100 is also in Phase I clinical trials and focuses on addressing pain, inflammation, and fever. This formulation aims to enhance the efficacy of ibuprofen while ensuring patient comfort and safety during use.
PLx Pharma distributes its products through a range of retail channels including pharmacies, major retailers, supermarkets, and online sales platforms. The company remains committed to the advancement of its product pipeline and the delivery of high-quality pharmaceutical solutions to consumers.
